Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes Branch, Galveston, TX 77550-2772 Communicated by Gordon H. Sato, November 15, 1985 ABSTRACT I have defined the basic requirements for the proliferation of cell lines expressing oligodendrocyte properties and for the survival of galactocerebroside-positive oligodendrocytes derived from neonatal rat brains. Conventional serum-containing medium can be replaced by 01 medium, a chemically defined medium supplemented with insulin, transferrin, sodium selenite, and biotin. Thyroid hormone is not required. When cells are plated directly into 01 medium, the substratum has to be modified by precoating with polylysine and adding fibronectin to the medium prior to the cells. Both cell lines and brain cells can be subcultured numerous times in 01 medium without initial culture in serum-containing medium. Brain cultures can be maintained in 01 medium for several months and contain a significantly higher percentage of mature oligodendrocytes, a lower number of astrocytes, and no fibroblasts as compared to cells maintained in serum-containing medium.
Oligodendrocytes in the central nervous system (CNS) and Schwann cells in the peripheral nervous system are responsible for forming multilayered myelin sheaths around neuronal axons, which increases their conduction velocity and consequently the efficiency of information transfer. It has been reported that some cultured oligodendrocytes are directly depolarized by y-aminobutyric acid (1) and exhibit diaminobutyric acid-sensitive y-aminobutyric acid uptake (2) , suggesting an additional role in modulating neuronal function. Although vertebrate cell culture studies have yielded important information about Schwann cell division, maturation, and interaction with neurons, much less is known about oligodendrocytes. Clearly, an understanding of the molecular regulation of survival, growth, and maturation of oligodendrocytes is important for the analysis of developmental and pathological processes.
Oligodendrocytes from late-term embryonic, neonatal, and adult CNS of several mammals have been maintained in vitro by using conventional culture methods (3) . These consist of a synthetic culture medium supplemented with undefined biological fluids, such as serum, plasma, and/or embryo extract, and culture surfaces unmodified or coated with collagen or polylysine. Most data reported describe dissociated cultures of mixed cellular phenotypes, although there are reports of enrichment for oligodendrocytes (3) . In neonatal CNS cultures, although neurons are present in the initial population of cells, they disappear within 1 week of in vitro culture leaving a bed layer of phase-contrast gray cells (astrocytes and connective tissue cells) with <2-5% phasecontrast dark, process-bearing cells (oligodendrocytes) on top (4) (5) (6) (8) (9) (10) and in adult rodents after trauma (11) .
Conventional culture methods appear to be suboptimal for the survival and proliferation of oligodendrocytes. Furthermore, the complexity, variability, and largely undefined nature of the biological fluid supplements preclude definition of the molecular growth requirements of oligodendrocytes. Thus, I have attempted to define the growth requirements of oligodendrocytes by using serum-free culture methods. The strategy of defining the requirements for growth of continuous cell lines expressing the phenotype of interest and applying this knowledge to culture of their normal cell counterparts has proven useful in the past for neurons and astrocytes (12) (13) (14) (15) (16) (17) (18) (19) . Although these cell lines are of tumor origin, they share some of the growth requirements of their normal cell counterparts. In addition, tumor cells often produce growth factors that act in an autocrine fashion to stimulate their own growth (20) . After determining the growth requirements of the appropriate cell line, I then evaluate whether normal cell counterparts have any additional requirements.
I now describe the growth requirements for oligodendrocytes. I used the recently established CO-13-7 clonal cell line for the initial phase of this investigation. It is a somatic cell hybrid of a normal calf brain oligodendrocyte fused with a C6 glial tumor cell (21 (16, 19) , the combined effect of all components is synergistic; each component alone has little or no effect and together the response is greater than the sum of individual effects (data not shown). The growth response to CO-13-7 cells as a function of supplement concentration is shown for insulin and transferrin in Fig. 2 . The maximum number of cells is obtained with 1-5 Ag of insulin/ml and 50 ,ug of transferrin/ml.
The following molecules had no growth-stimulating effect on CO-13-7 cells when added to 01 medium: 3,3'-5-triiodothyronine, 0.5 nM to 5 AtM; epidermal growth factor, 0.01-100 ng/ml; neurotensin, 0.01-3 ng/ml; angiotensin II, 65 fg/ml to 6.5 ng/ml; cyanocobalamin (vitamin B12), 0.1-10 pg/ml; choline chloride, 0.1-1 mM; carnitine hydrochloride, 1-100 ,uM; AlCl3, 1-100 jIM; VOS04, 1-10 AM; ZnSO4, 1-30 ,uM; CuS04, 1-100 ,uM; LiCl, KC1, or NaCl, 0.1-3 mM; and veratridine, 75 ,M. In contrast, several factors had growthinhibiting effects: 2.5S nerve growth factor, 0.01-100 ng/ml; VOS04, 30-100 ,uM; and choline chloride, 3-30 mM.
Somatomedin [insulin-like growth factor (IGF) I and II] receptors are present in brain (27) ; and insulin has a low affinity for IGF I receptors. Thus, I tested whether multiplication stimulating activity, which binds to IGF II receptors, could cause a further increase in CO-13-7 cell number if added to a saturating dose of insulin. Multiplication stimulating activity (1-150 ng/ml) had no effect in the absence or presence of insulin.
I also plated CO-13-7 cells on cell-free extracellular matrices produced by the following cells grown in the indicated CDM: CO-13-7 (01 medium), U-251 MGsp human astrocytoma (G2 medium; ref. 14) , LA-N-1 human neuroblastoma (N3 medium; ref. 16) , and neonatal rat brain astrocytes (G5 medium; ref. 18 ). Cells were removed at confluence with 0.02% EGTA in PBS without Ca2l or Mg2", and any residual cells were hypotonically lysed. There was no difference in the number of CO-13-7 cells when cultured on any of these cell-free extracellular matrices compared to a polylysine and fibronectin-modified substratum. Fig. 3 shows the morphology of CO-13-7 cells is similar in serum-supplemented or 01 medium; cells are phase-contrast dark and process bearing in both conditions but appear to be less mobile in 01 medium, forming flat clusters (Fig. 3C) . Cells are in poor condition in unsupplemented DMEM (Fig.  3B) .
I then evaluated the expression of several oligodendrocytespecific properties of CO-13-7 cells maintained in 01 medium. The cells continue to express immunoreactive GalCer, and there is a 2-fold increase in 2',3'-cyclic nucleotide Fig. 4 after two subcultures into serum-supplemented or 01 medium. Cells were immunostained for GalCer, the major myelin glycolipid and an early cell surface marker specific for mature oligodendrocytes (29) . Fig. 4A shows a single cell in serumsupplemented medium is GalCer-positive, <2% of the total population shown in Fig. 4B . In contrast, Fig. 4C shows several GalCer-positive cells in 01 medium, one with very long, extensively branched processes characteristic of mature oligodendrocytes. Fig. 4E Rat neuroblastoma 0 ± 0 Cells were plated directly into 01 medium at a density of 50,000 cells per 8 cm2 (C6-2B, 3T3, B104) (12) . Albumin, thyroxine (T4), and triiodothyronine (T3) were added to N2 supplements (insulin, transferrin, selenium, progesterone, and putrescine). N2 medium was optimized for neuronal survival or neuroblastoma proliferation and is suboptimal for Schwann cells and astrocytes (13, 16, 17) . Modified N2 medium favors oligodendrocyte differentiation in 7-day-old rat optic nerve cultures prepared from enzymatically dissociated tissue. In contrast, I find that the addition of progesterone, putrescine, albumin, T4, or T3 is not required in my culture system. A different CDM for culture of isolated oligodendrocytes from 5-to 10-day-old rat cerebra was described by Koper et al. (38) . Cells were maintained for 30 days in this CDM, which is very complex and contains 19 supplements, including the 4 supplements in 01 medium. After my initial data were presented (39), a CDM similar to the one reported here was described by Eccleston and Silberberg (40 Thus, 01 medium has several advantages over the various CDM described above. It is able to support proliferation of cell lines expressing oligodendrocyte properties in addition to maintaining a significantly higher percentage of mature oligodendrocytes, fewer astrocytes, and no fibroblasts compared to serum-supplemented medium. Also, it has fewer components than the other CDM and is notably lacking thyroid hormone. Cells can be subcultured several times in 01 medium and can even be plated directly into it, without initial culture in serum-containing medium, if the surface is modified with polylysine and fibronectin. Furthermore, cultures have been maintained in a healthy condition for longer periods of time in 01 medium than in the other CDM, i.e., several months vs. weeks. In addition, I also find that 01 medium can maintain for long periods of time isolated adult oligodendrocytes from both bovine and rat brain (41) , suggesting that 01 medium may not be species specific nor developmental stage specific.
Elucidation ofthyroid hormone action in the CNS has been hindered by the heterogeneity of the tissue. The role of this hormone in oligodendrocyte proliferation and maturation in vivo and in vitro is reviewed by Legrand (42) . Hypothyroid rats have normal numbers of oligodendrocytes, whereas hyperthyroid rats are deficient in oligodendrocytes. T3 also has no effect on [3H]thymidine incorporation or DNA content of fetal rat brain reaggregate cultures (43) . On the other hand, 2',3'-cyclic nucleotide 3'-phosphodiesterase activity and myelinogenesis are impaired in the hypothyroid state. Thus, thyroid hormone is not necessary for the proliferation of oligodendroblasts or the survival of mature oligodendrocytes. It also does not appear to be necessary for the expression of GalCer in 01 medium. Whether it is required for optimal levels of 2',3'-cycic nucleotide 3'-phosphodiesterase or for myelinogenesis in CDM has not yet been determined. It is also not known to what extent thyroid hormone effects on oligodendrocytes are direct or mediated through astrocytes or neurons.
Knowledge of the growth requirements of oligodendrocytes makes possible the use of a chemically defined medium and substratum, which will greatly extend the range, reproducibility, and ease of interpretation of future experiments. This will benefit studies of the regulation of oligodendrocyte proliferation and differentiation.
